Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin versus placebo for prevention of postoperative delirium after coronary artery bypass graft surgery
IRCT20120215009014N393Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Gabapentin with Placebo (2 arms). Primary endpoint: delirium. Started May 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20120215009014N393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N393.